Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadine Joffe

Showing results (51-60 of 198) with videos related to

Pageof 20
Sort By:
Sleep|December 3, 2013
A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleepHadine Joffe, Sybil Crawford, Nicole Economou, et al.
Archives of General Psychiatry|January 3, 2007
Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizationsBernard L Harlow, Allison F Vitonis, Par Sparen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 20, 2007
Relation of daily urinary hormone patterns to vasomotor symptoms in a racially/ethnically diverse sample of midlife women: study of women's health across the nationEllen B Gold, Bill Lasley, Sybil L Crawford, et al.
Menopause (New York, N.Y.)|July 4, 2013
Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected womenSara E Looby, Jan Shifren, Inge Corless, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2013
The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged womenH Irene Su, Kevin Maas, Patrick M Sluss, et al.
Menopause (New York, N.Y.)|July 7, 2022
Risk of high depressive symptoms after the final menstrual period: the Study of Women's Health Across the Nation (SWAN)Howard M Kravitz, Alicia B Colvin, Nancy E Avis, et al.
Contemporary Clinical Trials|March 5, 2022
Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019Alexandra Z Sosinsky, Janet W Rich-Edwards, Aleta Wiley, et al.
Obstetrics and Gynecology|February 23, 2012
Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trialSusan D Reed, Katherine A Guthrie, Hadine Joffe, et al.
Menopause (New York, N.Y.)|June 29, 2010
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trialHadine Joffe, Ann Partridge, Anita Giobbie-Hurder, et al.
Menopause (New York, N.Y.)|February 7, 2009
Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptomsHadine Joffe, Claudio N Soares, Rebecca C Thurston, et al.
Pageof 20

Showing results (51-60 of 198) with videos related to

Sort By:
Pageof 20
Sleep|December 3, 2013
A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleepHadine Joffe, Sybil Crawford, Nicole Economou, et al.
Archives of General Psychiatry|January 3, 2007
Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizationsBernard L Harlow, Allison F Vitonis, Par Sparen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 20, 2007
Relation of daily urinary hormone patterns to vasomotor symptoms in a racially/ethnically diverse sample of midlife women: study of women's health across the nationEllen B Gold, Bill Lasley, Sybil L Crawford, et al.
Menopause (New York, N.Y.)|July 4, 2013
Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected womenSara E Looby, Jan Shifren, Inge Corless, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2013
The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged womenH Irene Su, Kevin Maas, Patrick M Sluss, et al.
Menopause (New York, N.Y.)|July 7, 2022
Risk of high depressive symptoms after the final menstrual period: the Study of Women's Health Across the Nation (SWAN)Howard M Kravitz, Alicia B Colvin, Nancy E Avis, et al.
Contemporary Clinical Trials|March 5, 2022
Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019Alexandra Z Sosinsky, Janet W Rich-Edwards, Aleta Wiley, et al.
Obstetrics and Gynecology|February 23, 2012
Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trialSusan D Reed, Katherine A Guthrie, Hadine Joffe, et al.
Menopause (New York, N.Y.)|June 29, 2010
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trialHadine Joffe, Ann Partridge, Anita Giobbie-Hurder, et al.
Menopause (New York, N.Y.)|February 7, 2009
Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptomsHadine Joffe, Claudio N Soares, Rebecca C Thurston, et al.
Pageof 20